Programming megakaryocytes to produce engineered platelets for delivering non-native proteins.

Area of Science:

• Biotechnology
• Cell Biology
• Regenerative Medicine

Background:

• Platelets are anucleate cells containing secretory granules for protein release.
• Cell engineering offers potential for platelets to deliver non-native proteins.
• Megakaryocytes are progenitor cells that give rise to platelets.

Purpose of the Study:

• To develop a strategy for generating mouse platelets from pluripotent stem cells.
• To demonstrate the potential of engineered platelets as protein delivery platforms.
• To investigate the controlled release and therapeutic applications of engineered platelets.

Main Methods:

• Generating mouse platelets from pluripotent stem cells.
• Modifying megakaryocytes to engineer platelet protein cargo.
• Assessing the packaging and delivery capabilities of engineered platelets.

Main Results:

• Successfully generated mouse platelets from pluripotent stem cells.
• Engineered platelets demonstrated the ability to package and deliver non-native proteins.
• Engineered platelets can release proteins upon activation or deliver enzymes to alter recipient cells.

Conclusions:

• Platelets can be bioengineered from stem cells for protein delivery.
• Engineered platelets represent a promising platform for cell therapy applications.
• This approach enables controlled delivery of therapeutic proteins and genetic modification of cells.